Document is current
Any future updates will be listed below
-
Authors
Janssens, Katleen http://orcid.org/0000-0003-3987-4592
Lambrechts, Chinouk
Geerinckx, Barbara http://orcid.org/0000-0002-7687-2273
Op de Beeck, Ken http://orcid.org/0000-0001-5527-6838
Van Camp, Guy http://orcid.org/0000-0001-5105-9000
Oliveres, Helena http://orcid.org/0000-0003-1801-1181
Prenen, Hans http://orcid.org/0000-0001-8802-7352
Vandamme, Timon http://orcid.org/0000-0003-3701-5305
Peeters, Marc http://orcid.org/0000-0003-4969-2303
- License Information
-
More Information
Article History
Accepted: 10 April 2023
First Online: 22 May 2023
Compliance With Ethical Standards
:
: Dr. Janssens, dr. Lambrechts, dr. Geerinckx, dr. Oliveres, dr. Op de Beeck, and dr. Van Camp have nothing to disclose. Dr. Prenen reports personal fees from Amgen, personal fees from Roche, personal fees from Sanofi, personal fees from Astra Zeneca, personal fees from Bayer, outside the submitted work. Dr. Vandamme reports grants and non-financial support from Novartis, grants, personal fees and non-financial support from Ipsen, personal fees from Eisai, personal fees from Roche, personal fees from Bayer, personal fees and non-financial support from Servier, personal fees from Elmedix, outside the submitted work. Dr. Peeters reports other from Amgen, Bayer, Ipsen, Merck, MSD, Qurin, Remedus, Sanofi, Sirtex, Terumo, personal fees from Amgen, Bayer, BMS, Merck, MSD, Roche, Sanofi, Servier, Sirtex, grants from Amgen (Inst.), Bayer (Inst.), BMS (Inst.), Ipsen (Inst.), Novartis (Inst.), Roche (Inst.), outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
